Cell and Gene Therapy
Advancing Cell & Gene Therapy Research with Purpose-Built Technology and Expertise
Cell and gene therapy studies present some of the most complex operational challenges in clinical research. Personalized manufacturing, strict treatment timelines, long-term follow-up, and specialized site workflows require technology that can adapt to highly individualized participant journeys while maintaining regulatory compliance and high-quality data collection.
THREAD combines configurable clinical research technology with scientific consulting expertise to help sponsors design and execute cell and gene therapy studies more efficiently. Our Human-Centered Design approach simplifies complex study workflows, reduces participant burden, and supports long-term engagement throughout the entire treatment and follow-up lifecycle.
A Platform Built for the Complexity of Cell & Gene Therapy Studies
Cell and gene therapy trials often involve individualized treatment pathways, specialized site coordination, manufacturing milestones, complex scheduling, and years of participant follow-up. THREAD's no-code configurable platform enables sponsors to rapidly deploy studies while easily adapting to protocol changes without custom development.
Participants can complete eConsent, eCOA assessments, symptom diaries, telehealth visits, safety monitoring, and long-term follow-up using a single intuitive application. The platform supports configurable participant pathways, automated scheduling, role-based workflows, connected device integrations, remote monitoring, and multilingual participant experiences. Whether managing pre-treatment screening, manufacturing coordination, dosing visits, or post-treatment surveillance, THREAD provides a seamless experience for participants, caregivers, research sites, and study teams.
Consulting Services for Cell & Gene Therapy Research
Technology alone cannot overcome the complexity of advanced therapy clinical trials. THREAD's multidisciplinary consulting team partners with sponsors to optimize protocol design, participant engagement strategies, endpoint selection, and operational workflows before enrollment begins.
Our experts help organizations design participant-centric studies that improve recruitment, support complex site operations, reduce participant burden, and maximize long-term retention throughout extended safety follow-up. From first-in-human studies through pivotal registration trials and post-marketing surveillance, THREAD helps sponsors execute cell and gene therapy programs with greater operational efficiency and scientific confidence.
